Holen Sie sich die Stockscreener-App
2.31
2.21%
0.05
Handel nachbörslich:
2.31
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
1.179
|
- | - | - | - |
| Interest Income/Expense |
51.11%
0.592
|
1.211 | 0.826 | - | - |
| Operating Income/Loss |
23.60%
-2.962
|
-3.877 | -2.893 | -3.791 | -5.208 |
| Nonoperating Income/Loss |
72.32%
5.088
|
18.38 | 0.435 | - | - |
| Income/Loss From Continuing Operations Before Tax |
88.46%
1.534
|
13.30 | -3.284 | -1.313 | -3.611 |
| Income/Loss From Continuing Operations After Tax |
88.46%
1.534
|
13.30 | -3.284 | -1.313 | -3.611 |
Net Income/Loss
|
88.46%
1.534
|
13.30 | -3.284 | -1.313 | -3.611 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
95.00%
-0.002
|
-0.04 | -0.062 | -0.119 | -0.216 |
| Basic Average Shares |
59,468%
40.84
|
0.0686 | 40.45 | 40.23 | 40.04 |
| Diluted Average Shares |
12,873%
41.56
|
0.3204 | 40.45 | 40.23 | 40.04 |
| Basic Earnings Per Share |
180.00%
0.04
|
-0.05 | 0.08 | 0.03 | 0.08 |
| Diluted Earnings Per Share |
180.00%
0.04
|
-0.05 | 0.08 | 0.03 | 0.07 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):